Current status of glucose test prescription for hypertensive outpatients

References

• Gu D, Gupta A, Muntner P, et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation 2005;112:658–65.
   PubMed Web of Science ®Google Scholar
• Wang HY, Sun NL, Xi Y. Investigation and screening of glucose metabolism in essential hypertension patients without diagnosed diabetes mellitus. J Peking Univ Health Sci 2007;39:603–06.
   Google Scholar
• Hu DY, Liu LS, Yu JM, Yao CH. National survey of blood pressure control rate in Chinese hypertensive outpatients-China STATUS. Zhonghua Xin Xue Guan Bing Za Zhi 2010;38:230–38.
   PubMedGoogle Scholar
• Salmasi AM, Alimo A, Dancy M. Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic. Am J Hypertens 2004;17:483–88.
   PubMed Web of Science ®Google Scholar
• Chamnan P, Simmons RK, Jackson R, Khaw KT, Wareham NJ, Griffin SJ. Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia 2011;54:291–99.
   PubMed Web of Science ®Google Scholar
• Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2010;55:1169–77.
   PubMed Web of Science ®Google Scholar
• Maheux P, Jeppesen J, Sheu WH, et al. Additive effects of obesity, hypertension, and type-2 diabetes on insulin-resistance. Hypertension 1994;24:695–98.
   PubMed Web of Science ®Google Scholar
• Mantov S, Raev D. Additive effect of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis. Int J Cardiol 1996;56:145–48.
   PubMed Web of Science ®Google Scholar
• Tsao PS, Niebauer J, Buitrago R, et al. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioscler Thromb Vasc Biol 1998;18:947–53.
   PubMed Web of Science ®Google Scholar
• Palmieri V, Bella JN, Arnett DK, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects - hypertension genetic epidemiology network (HyperGEN) study. Circulation 2001;103:102–07.
   PubMed Web of Science ®Google Scholar
• Ballo P, Cameli M, Mondillo S, et al. Impact of diabetes and hypertension on left ventricular longitudinal systolic function. Diabetes Res Clin Pract 2010;90:209–15.
   PubMed Web of Science ®Google Scholar
• Russo C, Jin ZZ, Homma S, et al. Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail 2010;12:454–61.
   PubMed Web of Science ®Google Scholar
• Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl1): S62–69.
   Google Scholar
• Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007;35:390–419.
   Google Scholar
• Zhan Y, Tang Z, Yu J. Serum ferritin, diabetes, diabetes control, and insulin resistance. Acta Diabetol 2014;51(6):991–98.
   PubMed Web of Science ®Google Scholar
• Garcia-Puig J, Ruilope LM, Luque M, et al. Glucose metabolism in patients with essential hypertension. Am J Med 2006;119:318–26.
   PubMed Web of Science ®Google Scholar
• Sun Z, Zheng L, Xu C, et al. Prevalence of diabetes and impaired fasting glucose in hypertensive adults in rural China. Acta Cardiol 2009;64:351–56.
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Tuzcu EM, Kalidindi S, et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling. J Am Coll Cardiol 2008;52:255–62.
   PubMed Web of Science ®Google Scholar
• Association AD. Standards of medical care in diabetes-2010. Diabetes Care 2010;33:S11–61.
   Google Scholar
• Committee IE. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34.
   PubMed Web of Science ®Google Scholar
• Kilpatrick ES, Bloomgarden ZT, Zimmet PZ Is haemoglobin A1c a step forward for diagnosing diabetes? BMJ (Clin Res Ed) 2009;339:b4432.
   Google Scholar
• Bartoli E, Fra GP, Carnevale Schianca GP. The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med 2011;22:8–12.
   PubMed Web of Science ®Google Scholar
• ASSOCIATION AD. Standards of medical care in diabetes-2011. Diabetes Care 2011;34:S11–61.
   Google Scholar
• Qiao Q, Pyorala K, Pyorala M, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002;23:1267–75.
   PubMed Web of Science ®Google Scholar
• Hu D-Y, Pan C-Y, Yu J-M. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J 2006;27:2573–79.
   PubMed Web of Science ®Google Scholar
• Woolthuis EPK, de Grauw WJC, van Gerwen WHEM, et al. Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study. Ann Family Med 2009;7:422–30.
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med 2004;140:689–99.
   PubMed Web of Science ®Google Scholar
• Bartnik M, Ryden L, Ferrari R, et al, The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. Euro Heart Survey on diabetes and the heart. Eur Heart J 2004;25:1880–90.
   PubMed Web of Science ®Google Scholar
• Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88–136.
   PubMed Web of Science ®Google Scholar
• Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the anglo-danish-dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care 2015;41:1449–55.
   Web of Science ®Google Scholar
• Chatterjee R, Narayan KM, Lipscomb J, Phillips LS. Screening adults for pre-diabetes and diabetes may be cost saving. Diabetes Care 2010;33:1484–90.
   PubMed Web of Science ®Google Scholar
• Mosca L, Mochari H, Christian A, et al. National study of women’s awareness, preventive action, and barriers to cardiovascular health. Circulation 2006;113:525–34.
   PubMed Web of Science ®Google Scholar
• Ley SJ, Metcalf PA, Scragg RK, Swinburn BA Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Res Clin Pract 2004;63:103–12.
   PubMed Web of Science ®Google Scholar
• Iso H, Date C, Yamamoto A, et al. Smoking cessation and mortality from cardiovascular disease among japanese men and women - The JACC Study. Am J Epidemiol 2005;161:170–79.
   PubMed Web of Science ®Google Scholar
• Balducci S, Zanuso S, Nicolucci A, et al. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). Arch Intern Med 2010;170:1794–1803.
   PubMed Web of Science ®Google Scholar